Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The article concludes that surgeons should tailor facial surgery techniques for Asian males to their unique cultural and anatomical needs.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.